Lisa A. Carey, MD, FASCO
Nikhil Wagle, MD
In the last few years, cancer research has shifted from a focus on personalized treatment to one on precision medicine: treating cancer by targeting mutations based on findings from tumor tests. This changed focus has helped us develop new medicines and tests that benefit people with all types of metastatic breast cancer. But is precision medicine possible for most people today, or is it a sign of things to come? Our keynote session features a renowned researcher working to translate lab findings into treatments to benefit you in the doctor’s office, and a groundbreaking physician who can share the promise, and the perils, of precision medicine as it’s practiced today. Find out how the research is done, about different types of biomarker testing in tissue and blood, how doctors help you understand results, and ways to balance the implications of test results against other treatments available to you.
